Phosphorylated tau in Alzheimer's disease and other tauopathies

P Rawat, U Sehar, J Bisht, A Selman… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia in elderly people. Amyloid beta
(Aβ) deposits and neurofibrillary tangles are the major pathological features in an …

The neuropathology and cerebrovascular mechanisms of dementia

L Raz, J Knoefel, K Bhaskar - Journal of Cerebral Blood Flow …, 2016 - journals.sagepub.com
The prevalence of dementia is increasing in our aging population at an alarming rate.
Because of the heterogeneity of clinical presentation and complexity of disease …

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

JD Rohrer, IOC Woollacott, KM Dick, E Brotherhood… - Neurology, 2016 - AAN Enterprises
Objective: To investigate serum neurofilament light chain (NfL) concentrations in
frontotemporal dementia (FTD) and to see whether they are associated with the severity of …

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross …

JD Rohrer, JM Nicholas, DM Cash… - The Lancet …, 2015 - thelancet.com
Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …

Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death

X Wen, W Tan, T Westergard, K Krishnamurthy… - Neuron, 2014 - cell.com
Summary Expanded GGGGCC (G4C2) nucleotide repeats within the C9ORF72 gene are the
most common genetic mutation associated with both amyotrophic lateral sclerosis (ALS) and …

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

KM Moore, J Nicholas, M Grossman… - The Lancet …, 2020 - thelancet.com
Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with
about a third of cases being genetic. Most of this genetic component is accounted for by …

Neuroimaging in dementia: more than typical Alzheimer disease

S Haller, HR Jäger, MW Vernooij, F Barkhof - Radiology, 2023 - pubs.rsna.org
Alzheimer disease (AD) is the most common cause of dementia. The prevailing theory of the
underlying pathology assumes amyloid accumulation followed by tau protein aggregation …

Frontotemporal dementia, where do we stand? A narrative review

A Antonioni, EM Raho, P Lopriore, AP Pace… - International journal of …, 2023 - mdpi.com
Frontotemporal dementia (FTD) is a neurodegenerative disease of growing interest, since it
accounts for up to 10% of middle-age-onset dementias and entails a social, economic, and …

The prevalence and incidence of frontotemporal dementia: a systematic review

DB Hogan, N Jetté, KM Fiest, JI Roberts… - Canadian Journal of …, 2016 - cambridge.org
BackgroundPopulation-based prevalence and incidence studies are essential for
understanding the burden of frontotemporal dementia (FTD). MethodsThe MEDLINE and …

A histone acetylome-wide association study of Alzheimer's disease identifies disease-associated H3K27ac differences in the entorhinal cortex

SJ Marzi, SK Leung, T Ribarska, E Hannon… - Nature …, 2018 - nature.com
We quantified genome-wide patterns of lysine H3K27 acetylation (H3K27ac) in entorhinal
cortex samples from Alzheimer's disease (AD) cases and matched controls using chromatin …